
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Batliboi Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Order backlog has significantly improved from INR339 crores last year to nearly INR600 crores as of March 2026. Key concall takeaways from Batliboi Ltd's Q4…
7 Jun 2026
Aster DM Quality Care Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Mature hospitals show steady growth (~13.5-14% revenue growth YoY) with EBITDA expansion driven by complexity enhancement and oncology volume growth. Key…
7 Jun 2026
Narayana Hrudayalaya Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
EBITDA margin normalized to about 22% (excluding one-time acquisition cost impact) is the starting base, with efforts ongoing to improve margins. Key concall…
6 Jun 2026
Container Corporation Of India Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Handling volume: 9.5% overall . Key concall takeaways from Container Corporation Of India Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
6 Jun 2026
Ipca Laboratories Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Domestic branded business is guided to grow around 12% in FY27, with 1-2% from new products and the rest from price and volume increases. Key concall takeaways…
6 Jun 2026
Gujarat Fluorochemicals Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
INR 850 crores capex planned for FY '27 on chemical side: . Key concall takeaways from Gujarat Fluorochemicals Ltd's Q4 FY26 earnings call — and how it ranks…
6 Jun 2026
Fusion Finance Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
New client disbursement contribution is increasing, with 37% currently from new borrowers, striving towards 40% in FY27. Key concall takeaways from Fusion…
6 Jun 2026
Gulshan Polyols Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Capacity utilization in ethanol is currently around 80%, with unutilized capacity available up to 26 crore liters, allowing volume growth with increased…
6 Jun 2026
Thaai Casting Q4 FY26: Order Book ₹800 Cr | Arthneeti
Q4 FY26
The company secured significant new domestic orders worth approximately ₹126.53 crore to be executed over next 60 months, with fresh orders of around ₹76.6…
5 Jun 2026
Alkyl Amines Chemicals Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
FY26 volume was essentially flat, with minor fluctuations (±1%) (Page 7). Key concall takeaways from Alkyl Amines Chemicals Ltd's Q4 FY26 earnings call — and…
2 Jun 2026
AvenuesAI Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
AvenuesAI is making strategic investments in NBFCs, including a 2.5% stake in Ratnaafin, to enable embedded finance and lending without heavy balance sheet…
2 Jun 2026
Va Tech Wabag Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Order backlog grew 26% year-over-year, indicating strong revenue visibility. Key concall takeaways from Va Tech Wabag Ltd's Q4 FY26 earnings call — and how it…
2 Jun 2026
Tara Chand Infralogistic Solutions Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
The order book executable in FY '27 stands at INR 211.7 crores (INR2,117 million). Key concall takeaways from Tara Chand Infralogistic Solutions Ltd's Q4 FY26…
2 Jun 2026
Dachepalli Publishers Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
EBITDA Margins: Sustained and improved margins due to lower raw material costs and backward integration, with current EBITDA margins at ~25.7%. Key concall…
2 Jun 2026
Biocon Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
. Key concall takeaways from Biocon Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
1 Jun 2026
Netweb Technologies India Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
The strong order book at the start of the financial year, about INR2,400 crores (including L1 orders), exceeds the previous year's turnover, supporting…
1 Jun 2026
Kellton Tech Solutions Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
300 crores revenue in H1 FY'26, with an 11.1% year-on-year growth. Key concall takeaways from Kellton Tech Solutions Ltd's Q2 FY26 earnings call — and how it…
1 Jun 2026
Kellton Tech Solutions Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
. Key concall takeaways from Kellton Tech Solutions Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
1 Jun 2026
Vimta Labs Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Preclinical business supports both discovery (35%) and generic, specialty chemicals, regulatory work (65%). Key concall takeaways from Vimta Labs Ltd's Q2 FY26…
1 Jun 2026
Vimta Labs Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Management is striving to reach quarterly revenue run rates of INR 120-125 crores. Key concall takeaways from Vimta Labs Ltd's Q1 FY26 earnings call — and how…
1 Jun 2026